Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05259046 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health

Study acronym: InterVitaminK
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Oct 1, 2026 to Jan 30, 2027
    • Study completion date: Dec 1, 2026 to Feb 28, 2027
    • Site details revised
    v6
  2. Re-verified, no change to tracked fieldsv5
  3. Secondary endpoints: 10 to 7
    • Study description expanded, about 79 words
    • Eligibility criteria expanded, about 2 words
    v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v3
  5. Start date: Apr 1, 2022 to Jun 21, 2022v2 Show 4 more changesShow less
    • Interventions: Menaquinone-7 (MK-7) capsule (333 µg) (Dietary Supplement), Placebo capsule (Dietary Supplement) to Menaquinone-7 (MK-7) tablet (333 µg) (Dietary Supplement), Placebo tablet (Dietary Supplement)
    • Secondary endpoints: details revised at 1 of 10 entries
    • Study description revised
    • Eligibility criteria expanded, about 1 word
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to examine the effect of menaquinone-7 (MK-7) supplementation on cardiovascular, metabolic, and bone health.
Trial Details
NCT Number NCT05259046
Lead Sponsor Bispebjerg Hospital
Conditions
(from sponsor)		 Coronary Artery Calcification, Arterial Stiffness
Enrollment 450 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov